Celcuity announced it raised $35 Million in an amended filing from an offering of $75.4 Million

Company

Location

About

Celcuity is a clinical-stage, publicly traded biotechnology company seeking to extend the lives of cancer patients through the development of targeted therapies for the treatment of multiple solid tumor indications. The company was founded to develop a better way to treat the cellular drivers of tumor growth.